T2EVOLVE is a breakthrough alliance of academic and industry leaders in cancer immunotherapy which started in January 2021, under the European Union’s Innovative Medicines Initiative (IMI).

On the occasion of the Word Cancer Day, ECPC is launching the new HTA (Health Technology Assessment) toolkit

Following the Commission’s adoption of the European Beating Cancer Plan today, the Socialists and Democrats Group expressed their support for this initial positive step, calling for reinforced co-ordination and shared research among member states to ensure all citizens in the EU can rely on effective and high-quality treatment and care.

The S&D co-ordinator in the beating cancer committee, Alessandra Moretti MEP, stated:

Europe’s Beating Cancer plan is a welcome milestone to drive focused policy frameworks for cancer care in Europe. To achieve its mission, the cancer plan must support sustainable policies that improve access to generic, biosimilar and value added medicines. 

On Wednesday, 3 February, the main stakeholder organisations representing the forestry sector met with the European Commissioner for Agriculture, Janusz Wojciechowski, to discuss the sector's growing concerns on the way in which the implementation of the EU Green Deal currently addresses forestry issues. Our forests need to be responsibly managed, especially in the face of climate change and its impact on forest holdings.